Guj. Themis Bio.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE942C01045
  • NSEID: GUJTHEM
  • BSEID: 506879
INR
309.60
-1.8 (-0.58%)
BSENSE

Jan 29

BSE+NSE Vol: 1.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Senores Pharma.
SMS Pharma.
Aarti Drugs
Innova Captab
Guj. Themis Bio.
Advanced Enzyme
RPG LifeScience.
Dishman Carbogen
Gufic BioScience
Orchid Pharma
SPARC

Why is Gujarat Themis Biosyn Ltd ?

1
Poor long term growth as Net Sales has grown by an annual rate of 9.27% and Operating profit at 5.21% over the last 5 years
2
Flat results in Sep 25
  • ROCE(HY) Lowest at 19.25%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.42 times
3
With ROCE of 19, it has a Very Expensive valuation with a 10.6 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 0.00%, its profits have fallen by -8.4%
4
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.99% over the previous quarter and collectively hold 3.14% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.27%
EBIT Growth (5y)
5.21%
EBIT to Interest (avg)
62.69
Debt to EBITDA (avg)
0.17
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.96
Tax Ratio
24.98%
Dividend Payout Ratio
36.63%
Pledged Shares
4.49%
Institutional Holding
3.14%
ROCE (avg)
50.79%
ROE (avg)
32.79%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
70
Industry P/E
33
Price to Book Value
12.78
EV to EBIT
55.53
EV to EBITDA
49.34
EV to Capital Employed
10.56
EV to Sales
22.14
PEG Ratio
NA
Dividend Yield
0.22%
ROCE (Latest)
19.02%
ROE (Latest)
18.26%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(Q)

Highest at Rs 42.35 cr

PBDIT(Q)

Highest at Rs 20.95 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 49.47%

PBT LESS OI(Q)

At Rs 17.94 cr has Grown at 24.5% (vs previous 4Q average

PAT(Q)

Highest at Rs 14.26 cr.

EPS(Q)

Highest at Rs 1.31

-7What is not working for the Company
ROCE(HY)

Lowest at 19.25%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.42 times

Loading Valuation Snapshot...

Here's what is working for Guj. Themis Bio.

Net Sales - Quarterly
Highest at Rs 42.35 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 20.95 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 49.47%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 17.94 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 17.94 cr has Grown at 24.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 14.41 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 14.26 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 14.26 cr has Grown at 27.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 11.15 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 1.31
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Guj. Themis Bio.

Debtors Turnover Ratio- Half Yearly
Lowest at 4.42 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio